Race Oncology Ltd raises A$29.7 million to accelerate Zantrene plans
“The number of applications reflects enthusiasm for the significant potential of our lead drug Zantrene and this enables us to implement our...
Source: proactiveinvestors.com
Page 4 - Three Pillar News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Three Pillar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Three Pillar Today - Breaking & Trending Today
Race Oncology Ltd raises A$29.7 million to accelerate Zantrene plans
“The number of applications reflects enthusiasm for the significant potential of our lead drug Zantrene and this enables us to implement our...
Source: proactiveinvestors.com.au
Race Oncology Ltd interim results for Zantrene oncology treatment "remarkable", protects heart from cell death during chemotherapy
“Zantrene is the first anti-cancer agent that we have found to exhibit a cardioprotective profile while being synergistically effective as an...
Source: proactiveinvestors.com.au
Race Oncology Ltd interim results for Zantrene oncology treatment "remarkable", protects heart from cell death during chemotherapy
“Zantrene is the first anti-cancer agent that we have found to exhibit a cardioprotective profile while being synergistically effective as an...
Source: proactiveinvestors.com
Race Oncology Ltd targets multiple cancer indications as it advances Zantrene
Clinical stage RNA focused company targeting multiple cancer indications with estimated annual oncology revenues of >US$2.6 billion
Source: proactiveinvestors.com.au